Support The Moscow Times!

Russia Breaks One-Day Coronavirus Record With 22K Infections

The virus has increasingly strained hospitals in Russia's regions but authorities are holding off on a second lockdown. Sophia Sandurskaya / Moskva News Agency

Russia confirmed more than 22,000 coronavirus infections in a single day for the first time since the start of the pandemic as the authorities continue to hold off on widespread lockdown measures.

Saturday's increase of 22,702 Covid-19 cases brings the country's official total to 1,903,253, the world’s fifth-highest count behind France, Brazil, India and the United States.

Russia's coronavirus information center, whose daily figures are widely thought to be undercounted, confirmed 391 deaths nationwide, bringing the total death toll to 32,834.

Monthly state statistics that scrutinize death certificates say 55,671 people have died from Covid-19 between April and September, the latest available month.

While Moscow remains the epicenter of the pandemic within Russia, the virus has increasingly strained hospitals in Russia's regions as the second wave has taken hold, with severe shortages of hospital beds, staff and medicine reported across the country.

In recent weeks Russia has re-imposed a nationwide mask mandate and advised regional leaders to close late-night bars, nightclubs and other establishments but has held off on wider lockdown measures, citing the need to keep businesses open.

Russian authorities have placed their hopes on the domestically developed Sputnik V vaccine, which is currently undergoing Phase 3 trials involving 40,000 volunteers after being approved in August. The vaccine, which has been administered to several high-ranking officials as well as medics and other at-risk groups, has been met with skepticism by international observers, who warn that mass trials guaranteeing its safety and effectiveness must be completed before administering it to civilians.

Sputnik V's developers this week said that the vaccine's interim data shows a 92% effectiveness rate.

The interim results follow the announcement by U.S. pharmaceutical giant Pfizer and Germany's BioNTech that their vaccine, which is also undergoing Phase 3 trials, was 90% effective at preventing Covid-19.

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysiss and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more